Comprehensive raw material testing for pharmaceutical APIs and excipients from an NABL-accredited laboratory in India.
Pharmaceutical raw material testing is the first quality gate in the drug manufacturing process. Every API and excipient entering your facility must be tested against pharmacopoeial or in-house specifications before release for production. Auriga Research provides NABL-accredited raw material testing services covering identity, purity, assay, impurities, moisture, microbial quality, and physical characterisation per IP, USP, EP, BP, and JP monographs.
For APIs, our testing scope includes identification by IR spectroscopy, assay by HPLC or titration, related substances profiling, residual solvents by GC-HS, elemental impurities by ICP-MS, water content by Karl Fischer, and polymorphic form confirmation by XRD or DSC. For excipients, we test identity, functional properties, microbial limits, and critical quality attributes specific to each material's role in the formulation.
Our laboratory supports pharmaceutical manufacturers, contract manufacturing organisations (CMOs), and API producers with reliable incoming material testing that meets cGMP documentation requirements. Test reports include certificate of analysis (CoA), raw data traceability, and pharmacopoeial compliance statements.
NABL-accredited API and excipient testing per IP, USP, EP, BP pharmacopoeias. Reliable incoming material release within 5-7 business days.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing